从脾论治肝癌的临床和理论溯源
Clinical and Theoretical Roots for Treatment of Liver Cancer from Spleen
DOI: 10.12677/WJCR.2016.64005, PDF, HTML, XML, 下载: 1,575  浏览: 4,578 
作者: 李美霞*:天津中医药大学,天津;田 菲:天津中医药大学第一附属医院,天津
关键词: 肝癌脾虚从脾论治Liver Cancer Insufficiency of the Spleen Treatment Determination from Spleen
摘要: 目的:探析从脾论治肝癌的临床和理论溯源。方法:通过临床观察、收集病例、查阅文献资料,从病因病机、临床研究、临床验案等方面进行总结论述。结果:通过总结发现,从脾论治肝癌临床疗效显著。结论:肝癌患者多有脾虚之候,从脾论治肝癌临床疗效确切,确为中医药治疗肝癌之验法之一。
Abstract: Objective: To explore and analyze clinical and theoretical roots for treatment of liver cancer from spleen. Methods: Through clinical observation, collecting cases and referring to literature, this paper is summarized from aspects of the etiology and pathology, clinical studies and clinical cases. Results: Through summarizing, the effect of clinical and theoretical roots for treatment of liver cancer from spleen is distinct. Conclusion: Patients with liver cancer most have the syndrome of spleen deficient; the effect of clinical and theoretical roots for treatment of liver cancer from spleen is distinct; it is one of the test methods of traditional Chinese medicine treatment of liver cancer.
文章引用:李美霞, 田菲. 从脾论治肝癌的临床和理论溯源[J]. 世界肿瘤研究, 2016, 6(4): 27-30. http://dx.doi.org/10.12677/WJCR.2016.64005

参考文献

[1] 高杰, 朱继业. 卫生部《原发性肝癌诊疗规范(2011年版)》解读[J]. 中华普通外科杂志, 2012, 27(8): 693-695.
[2] 刘亚娴. 中西医结合肿瘤病学[M]. 北京: 中国中医药出版社, 2005: 318.
[3] 韩钦芮, 符秀琼, 禹志领, 等. 肿瘤微环境的脾虚本质探讨[J]. 中医杂志, 2014, 55(4): 292-294, 298.
[4] 郑舞, 杨金坤. 肿瘤微环境及其中医病机[J]. 中医杂志, 2015, 56(20): 1720-1724.
[5] 罗安明. 试论肿瘤的中医本质——脾虚[J]. 江苏中医药, 2013, 45(2): 8-9.
[6] 张建伟, 王苹.《金匮要略》“见肝之病, 知肝传脾, 当先实脾”之管见[J]. 甘肃中医学院学报, 2012, 29(1): 21-23.
[7] 孙保国, 邓六香, 陈泽雄, 等. 加味健脾解毒方抗小鼠腹水肝癌恶液质模型的机制研究[J]. 中华中医药学刊, 2015, 33(12): 2830-2835.
[8] 凌博凡, 王瑞平, 邹玺, 等. 健脾化瘀方对肝癌bel-7402/5-FU细胞表面耐药蛋白影响的研究[J]. 世界中西医结合杂志, 2013, 8(2): 120-123.
[9] 山广志, 邱慧颖, 史国军, 等. 健脾柔肝汤对荷肝癌H22小鼠肿瘤组织VEGF表达的影响[J]. 中华中医药学刊, 2014, 32(10): 2465-2468.